Jong-Hwa Park
Director/Board Member presso CLINOMICS INC.
Patrimonio netto: 3 M $ in data 31/03/2024
Profilo
Jong-Hwa Park is currently the Chief Executive Officer at Geromics, Inc. and the Director at Clinomics, Inc. He has an undergraduate degree from the University of Aberdeen and a doctorate degree from the University of Cambridge.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
CLINOMICS, INC.
7.38% | 24/04/2024 | 2 453 373 ( 7.38% ) | 3 M $ | 31/03/2024 |
Posizioni attive di Jong-Hwa Park
Società | Posizione | Inizio |
---|---|---|
CLINOMICS INC. | Director/Board Member | 01/09/2018 |
Geromics, Inc.
Geromics, Inc. Miscellaneous Commercial ServicesCommercial Services Geromics, Inc. engages in the research and development of bio technologies. Its services include bio information technology, genetic test, life science research support, and others. The company was founded on November 18, 2014 and is headquartered in Ulsan, South Korea. | Chief Executive Officer | - |
Formazione di Jong-Hwa Park
University of Aberdeen | Undergraduate Degree |
University of Cambridge | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Clinomics, Inc. | |
Geromics, Inc.
Geromics, Inc. Miscellaneous Commercial ServicesCommercial Services Geromics, Inc. engages in the research and development of bio technologies. Its services include bio information technology, genetic test, life science research support, and others. The company was founded on November 18, 2014 and is headquartered in Ulsan, South Korea. | Commercial Services |
- Borsa valori
- Insiders
- Jong-Hwa Park